Related Experiment Video
Updated: Aug 14, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Treatment of acute sinusitis in childhood with ceftibuten
1Department of Pediatrics, University of Kentucky, Lexington, USA.
Abstract:
Acute sinusitis is a common childhood illness. If it is overlooked or undertreated, suppurative and intracranial complications may develop. Amoxicillin has traditionally been the antibiotic of choice for treatment of acute sinusitis. However, the efficacy of amoxicillin has been reduced because of the emergence of bacteria producing b-lactamase and altered penicillin-binding proteins. This study compares the effectiveness of 10, 15, and 20 days of ceftibuten therapy with 14 days of erythromycin-sulfisoxazole therapy in treating acute sinusitis. The results indicate that both treatment regimens are effective in treating acute sinusitis (96% clinical response for erythromycin-sulfisoxazole vs 92% for a 10- or 15-day course of ceftibuten vs 100% for a 20-day course of ceftibuten). Longer treatment periods may be more effective in resolving the acute illness.
Insights
This study found that longer treatment durations for acute sinusitis in children may improve outcomes. A 20-day course of ceftibuten showed 100% effectiveness, compared to other regimens.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pharmacology
Background:
- Acute sinusitis is a frequent pediatric illness with potential for serious complications if untreated.
- Amoxicillin resistance due to beta-lactamase producing bacteria and altered penicillin-binding proteins impacts treatment efficacy.
- Novel antibiotic strategies are needed for effective acute sinusitis management in children.
Purpose of the Study:
- To compare the clinical effectiveness of varying durations of ceftibuten therapy (10, 15, and 20 days) against erythromycin-sulfisoxazole (14 days) for treating acute sinusitis in children.
Main Methods:
- A comparative study evaluating treatment outcomes for acute sinusitis.
- Patients received either 10, 15, or 20 days of ceftibuten or 14 days of erythromycin-sulfisoxazole.
- Clinical response rates were assessed for each treatment group.
Main Results:
- Both ceftibuten and erythromycin-sulfisoxazole demonstrated high clinical response rates.
- Erythromycin-sulfisoxazole achieved a 96% clinical response.
- Ceftibuten showed a 92% response for 10- or 15-day courses and 100% for a 20-day course.
Conclusions:
- Ceftibuten and erythromycin-sulfisoxazole are effective treatments for pediatric acute sinusitis.
- A 20-day course of ceftibuten therapy resulted in the highest clinical resolution rate (100%).
- Extended treatment durations may enhance the resolution of acute sinusitis in children.
Related Concept Videos
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management
Acne Infection
Respiratory Syncytial Virus Disease

